Area of research
Molecular Biology · Oncology
Research interest
Research focused on Methylation and Cancer research, with related work in Bladder cancer, DU145, Clear cell renal cell carcinoma. Notable publications include 'Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer', 'Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer', and 'Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer'.
TAZ/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis
Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer
Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma
Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer